Sitaxa E 25+100 Tablet

Description

Sitaxa E 25+100 Tablet is a combination anti-diabetic medication containing Empagliflozin and Sitagliptin. Empagliflozin, an SGLT2 inhibitor, lowers blood sugar by promoting glucose excretion through urine. Sitagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, stimulating insulin secretion and reducing post-meal glucose production.
This combination is prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy does not achieve adequate glycemic control.

---

Uses:

• Controls high blood sugar in Type 2 diabetes

• Reduces post-meal glucose spikes

• Enhances insulin secretion

• Supports weight management via glucose excretion

• Helps prevent diabetes-related complications

---

Dosage:

• Usually one tablet once daily, or as directed by the doctor

• Can be taken with or without food

---

How to Use:

• Swallow the tablet whole with water

• Take at the same time each day

• Continue prescribed diet and exercise routine

---

Precautions:

• Not for Type 1 diabetes or diabetic ketoacidosis

• Use cautiously in patients with kidney disease or urinary tract infections

• Monitor for dehydration or low blood pressure

• Consult doctor if pregnant or breastfeeding

---

Side Effects:

• Increased urination

• Urinary or genital infections

• Low blood sugar (hypoglycemia) if combined with other anti-diabetic drugs

• Stomach upset, nausea

• Rare: allergic reactions